Introduction of Liuwei Dihuang Pill Enterprise in Jiuzhitang

Jiuzhitang Co., Ltd. is a national key Chinese medicine enterprise, a domestic A-share listed company, a key high-tech enterprise in Hunan Province, a top 100 enterprise in Hunan Province, an award-winning enterprise in quality management, a leading enterprise in the top ten industrial landmark projects in Changsha, and a national post-doctoral research mobile station enterprise.

The old Jiuzhitang Pharmacy, the predecessor of Jiuzhitang, was established in 1650. In February 2004, Jiuzhitang trademark was recognized as a well-known trademark in China by the Trademark Office of the State Administration for Industry and Commerce. In September 2006, "Jiuzhitang" was recognized as "China's time-honored brand" by the Ministry of Commerce. In June 2008, Jiuzhitang traditional Chinese medicine culture was listed in the national intangible cultural heritage protection list. By the end of 2008, the company has developed into a modern large-scale pharmaceutical enterprise with total assets of 65.438+0.546 billion yuan, net assets of 65.438+0.28 billion yuan, seven directly controlled subsidiaries, three indirectly controlled subsidiaries and 65.438+0 branches, with annual sales of 65.438+0.2 billion yuan and profits and taxes of more than 300 million yuan.

The company is mainly engaged in the production and sales of blood-enriching series, nourishing series, diabetes drugs, hepatitis series and other traditional Chinese medicines, as well as the biological agent Siqikang, which regulates human immunity. It has formed a product ladder composed of products with sales of over 100 million, over 10 million and rapid growth, laying a product foundation for sustainable development. The leading product, Lvjiao Buxue Granule, has an annual sales income of more than 300 million yuan, ranking the top three in the national sales of natural blood-enriching products. The sales income of concentrated pills represented by Liuwei Dihuang Pills exceeds 200 million yuan, ranking the top three in the sales of similar products in China. The sales income of Siqikang injection was 654.38 billion yuan. The company's Chinese patent medicine tablets, Yuquan pills and other concentrated pills are exported to Europe, America, Japan, Southeast Asia and other regions, of which more than ten kinds of concentrated pills and tablets have been exported to Japan for nearly 20 years. Jiuzhitang's products are not only the best medicine in the world, but also a cultural carrier. Jiuzhitang people are not only businessmen, but also cultural messengers.

The comprehensive economic strength of the company ranks first in the pharmaceutical industry in Hunan Province, and it has become the core enterprise of the advantageous industrial cluster of modern Chinese medicine and biomedicine, which is focused on the development in the 11th Five-Year Plan of Hunan Province. In August 2006, Jiuzhitang ranked 13 in the "Top 100 Chinese Time-honored Brands" with a brand value of135.5 billion. In April, 2007, Jiuzhitang was once again rated as "Top 100 Pharmaceutical Enterprises in China" by SFDA Southern Pharmaceutical Economic Research Institute. From June, 5438 to February, 2008, the company passed the re-certification of Hunan Science and Technology Department and won the title of "High-tech Enterprise".